Ascendis Pharma A/S vs McCormick & Company, Incorporated — how do they compare? Ascendis Pharma A/S trades at $254.5 (market cap $16.67B), while McCormick & Company, Incorporated trades at $53 (market cap $14.22B). The key difference: Ascendis Pharma A/S is the larger of the two by market cap, and McCormick & Company, Incorporated pays a 3.63% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | MKC | |
|---|---|---|
Market Cap | $16.67B | $14.22B |
Sector | Health | Consumer Staples |
52-Week High | $277.18 | $72.26 |
52-Week Low | $189.74 | $45.60 |
Enterprise Value | $17.04B | $18.82B |
Dividend Yield | — | 3.63% |
Trailing returns across standard periods
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →In its 130-year history, McCormick has grown to become the leading global manufacturer, marketer, and distributor of spices, herbs, extracts, seasonings, and other flavorings. Beyond end consumers, McCormick's customer base also includes top quick-service restaurants, retail grocery chains, and other packaged food and beverage manufacturers, with about 30% of sales generated beyond its home turf to include 150 other countries and territories. In addition to its namesake brand, the firm's portfolio includes Old Bay, Zatarain's, Thai Kitchen, Frank's RedHot, French's, and the recently acquired Cholula brand.
Read more on MKC →